** Benchmark lifts price target on aircraft generic parts maker HEICO Corp HEI.N to $285 from $245
** New PT represents a 8.5% upside to the stock's last close
** Brokerage says continued adoption of parts manufacturer approval (PMA) components, or generic components, by Asian markets and international airlines a tailwind for HEI
** Also notes growth upside from HEI's pricing power from market share gains post COVID, incoming Trump administration's likely support for PMA approvals and Wencor synergies
** Thirteen brokerages rate the stock "buy" or higher and seven "hold"; their median PT is $278.50 - LSEG data
** As of last close, stock had risen ~47% YTD
(Reporting by Aatreyee Dasgupta)
((Aatreyee.Dasgupta@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。